THE GREEN MOUNTAIN ONCOLOGY GROUP/CCOP in an NCI funded consortium of the three full-time Community Oncologists in Vermont which has functioned since 1983 as a regional clinical cooperative group in close cooperation with the University of Vermont/Vermont Regional Cancer Center. The members of GMOG/CCOP are active members of EASTERN COOPERATIVE ONCOLOGY GROUP and NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT and have brought clinical research to the community. The GMOG/CCOP is maturing into a solid multidisciplinary organization of health care professionals based on the premise that: 1. Until we have truly effective treatments for all cancers, the patient and community are best served by a continuing emphasis on research as a model for optimal care. 2. A regional cooperative network linking the community with the University for cancer control efforts in prevention, management, and research will better utilize resources in the Green Mountain Region. The GMOG/CCOP will continue its major emphasis in participation in clinical research trials of ECOG and NSABP with anticipated accrual of 60 patient credits on these protocols. We plan to enhance our present data management by implementing electronic data processing and telecommunication between components - the Operations Office and Data Management Center and also the research bases. Cancer Control Research Studies will be carried out by implementing protocols proposed by ECOG and NSABP with estimated accrual of 30 or more cancer control credits in Year 01. GMOG is planning a local initiative in smoking cessation aimed at health care workers, especially nurses, using Dr. Roger Secker-Walker of the University as our consultant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA035091-06
Application #
3557461
Study Section
(SRC)
Project Start
1983-09-30
Project End
1990-05-31
Budget Start
1989-08-15
Budget End
1990-05-31
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Rutland Regional Medical Center
Department
Type
DUNS #
City
Rutland
State
VT
Country
United States
Zip Code
05701
Kolitz, Jonathan E; George, Stephen L; Benson Jr, Don M et al. (2014) Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808. Cancer 120:1010-7
Demmy, Todd L; Gu, Lin; Burkhalter, Jack E et al. (2012) Optimal management of malignant pleural effusions (results of CALGB 30102). J Natl Compr Canc Netw 10:975-82
Bertagnolli, Monica M; Redston, Mark; Compton, Carolyn C et al. (2011) Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. J Clin Oncol 29:3153-62
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (2010) Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol 28:1247-53
Blanke, Charles D; Rankin, Cathryn; Demetri, George D et al. (2008) Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 26:626-32
Rocha-Lima, C M; Herndon 2nd, J E; Lee, M E et al. (2007) Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902. Ann Oncol 18:331-7
Lamont, Elizabeth B; Herndon 2nd, James E; Weeks, Jane C et al. (2006) Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst 98:1335-8
Halabi, Susan; Vogelzang, Nicholas J; Ou, San-San et al. (2006) Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies. J Urol 176:81-6
Muss, Hyman B; Woolf, Susan; Berry, Donald et al. (2005) Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293:1073-81
Bogart, Jeffrey A; Herndon 2nd, James E; Lyss, Alan P et al. (2004) 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808. Int J Radiat Oncol Biol Phys 59:460-8

Showing the most recent 10 out of 18 publications